148 related articles for article (PubMed ID: 468510)
1. Studies on lactic dehydrogenase of patients with urinary bladder tumors. I. Urinary lactic dehydrogenase.
Motomiya Y; Ohzono S; Shiomi T; Kondo T; Ijuin M; Okajima E
Invest Urol; 1979 Sep; 17(2):120-4. PubMed ID: 468510
[TBL] [Abstract][Full Text] [Related]
2. Urine cytology in bladder tumors.
Zein TA; Milad MF
Int Surg; 1991; 76(1):52-4. PubMed ID: 2045253
[TBL] [Abstract][Full Text] [Related]
3. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
Kumar A; Kumar R; Gupta NP
Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
Durkan GC; Nutt JE; Rajjayabun PH; Neal DE; Lunec J; Mellon JK
Clin Cancer Res; 2001 Nov; 7(11):3450-6. PubMed ID: 11705862
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma.
Nisman B; Barak V; Shapiro A; Golijanin D; Peretz T; Pode D
Cancer; 2002 Jun; 94(11):2914-22. PubMed ID: 12115379
[TBL] [Abstract][Full Text] [Related]
6. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
8. Studies on urinary isozymes of lactic dehydrogenase and beta-glucuronidase in patients with bladder tumors.
Motomiya Y; Yamada K; Matsushima S; Ijyuin M; Iriya K
Urol Res; 1975 May; 3(1):41-8. PubMed ID: 1136080
[TBL] [Abstract][Full Text] [Related]
9. [Quantification of bladder tumor antigen (BTA trak) and its correlation with bladder cancer grade and stage].
Rodríguez Martínez JJ; Escaf Barmadah S; Allende MT; Raigoso P; Martín Benito JL; Pérez García FJ; Fernández Gómez JM
Arch Esp Urol; 2000; 53(1):1-6. PubMed ID: 10730418
[TBL] [Abstract][Full Text] [Related]
10. [Changes of urinary enzyme activity in cancer of the urinary bladder].
Nizamova RS
Vopr Onkol; 2006; 52(4):455-7. PubMed ID: 17024822
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology.
Shariat SF; Casella R; Wians FH; Ashfaq R; Balko J; Sulser T; Gasser TC; Sagalowsky AI
Eur Urol; 2004 Mar; 45(3):304-13; author reply 313. PubMed ID: 15036675
[TBL] [Abstract][Full Text] [Related]
12. [Enzymological study of bladder tumor. II. Lactic dehydrogenase, alkaline phosphatase activity and LDH isoenzymes in the tissue of bladder cancer: the relations with stage and histological grade].
Ishibe T; Nihira H
Hinyokika Kiyo; 1970 Feb; 16(2):68-72. PubMed ID: 5462080
[No Abstract] [Full Text] [Related]
13. [Clinical study of urinary cytology: with special reference to bladder cancer].
Nemoto S; Ishikawa S; Takeshima H; Iizumi T; Uchida K; Yazaki T; Nemoto R; Rinsho K; Kano S
Hinyokika Kiyo; 1983 Dec; 29(12):1611-5. PubMed ID: 6677108
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological study of urinary bladder tumors. Clinical evaluation of immunohistochemistry in urine cytology].
Nagata Y; Kinoshita H; Kawamura N; Sasadaira S
Hinyokika Kiyo; 1985 Nov; 31(11):1931-7. PubMed ID: 4091136
[TBL] [Abstract][Full Text] [Related]
15. Voided urinary cytology in bladder cancer: is it time to review the indications?
Talwar R; Sinha T; Karan SC; Doddamani D; Sandhu A; Sethi GS; Srivastava A; Narang V; Agarwal A; Adhlakha N
Urology; 2007 Aug; 70(2):267-71. PubMed ID: 17826487
[TBL] [Abstract][Full Text] [Related]
16. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
17. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
[TBL] [Abstract][Full Text] [Related]
18. [Urine cytology as a supplement to cystoscopy and biopsy in the control of bladder tumors].
Andersen OP; Ladefoged C; Røhl HF; Osther P; Holm K
Ugeskr Laeger; 1989 Dec; 151(50):3400-1. PubMed ID: 2609449
[TBL] [Abstract][Full Text] [Related]
19. The characteristics of hepatocellular carcinoma with a high level of serum lactic dehydrogenase: a case report.
Fujiwara Y; Takenaka K; Kajiyama K; Maeda T; Gion T; Shirabe K; Shimada M; Sugimachi K
Hepatogastroenterology; 1997; 44(15):820-3. PubMed ID: 9222698
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the increasing serum lactate dehydrogenase caused by recombinant human granulocyte-colony stimulating factor].
Sawa T; Yoshida T; Ikoma T; Toyoda M; Ohno Y; Fujiwara H
Gan To Kagaku Ryoho; 2003 Jan; 30(1):51-8. PubMed ID: 12557705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
